JACC. Case reports · 2026
Compound MYH7 Mutations: Risk Stratification Challenges in an Affected Family.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hammad Arafat, Yeung Amy, Goldschmidt Howard, Gupta Himanshu, Musat Dan, Mittal Suneet, Habibi Mohammadali
Аннотация
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous disease associated with sudden cardiac death (SCD). Risk stratification is challenging in genotype-positive individuals with borderline phenotypic expression.
CASE SUMMARY: A 54-year-old man was referred for SCD risk stratification in familial HCM. His daughter had obstructive HCM, underwent septal myomectomy, and received an implantable cardioverter-defibrillator after a cardiac arrest. The patient was asymptomatic with mild septal hypertrophy and nonsustained ventricular tachycardia. Genetic testing revealed 2 pathogenic MYH7 variants in his daughter (Ala655Thr and Gly571Arg); the patient carried only Ala655Thr, whereas his wife carried Gly571Arg. Repeat cardiac magnetic resonance imaging (MRI) under anesthesia revealed late gadolinium enhancement burden of 23%, prompting implantable cardioverter-defibrillator insertion.
DISCUSSION: This case underscores the value of cardiac MRI and genetic testing in individualizing SCD risk assessment when conventional HCM markers are insufficient.
TAKE-HOME MESSAGES: Genotype-phenotype discordance in familial HCM underscores the need for family-based genetic evaluation and individualized risk stratification. Cardiac MRI is invaluable for SCD risk assessment in ambiguous cases.
CASE SUMMARY: A 54-year-old man was referred for SCD risk stratification in familial HCM. His daughter had obstructive HCM, underwent septal myomectomy, and received an implantable cardioverter-defibrillator after a cardiac arrest. The patient was asymptomatic with mild septal hypertrophy and nonsustained ventricular tachycardia. Genetic testing revealed 2 pathogenic MYH7 variants in his daughter (Ala655Thr and Gly571Arg); the patient carried only Ala655Thr, whereas his wife carried Gly571Arg. Repeat cardiac magnetic resonance imaging (MRI) under anesthesia revealed late gadolinium enhancement burden of 23%, prompting implantable cardioverter-defibrillator insertion.
DISCUSSION: This case underscores the value of cardiac MRI and genetic testing in individualizing SCD risk assessment when conventional HCM markers are insufficient.
TAKE-HOME MESSAGES: Genotype-phenotype discordance in familial HCM underscores the need for family-based genetic evaluation and individualized risk stratification. Cardiac MRI is invaluable for SCD risk assessment in ambiguous cases.